Influx Healthtech IPO
Influx Healthtech IPO
Influx Healthtech Ltd
₹1,09,200 / 1200 Shares
Minimum Investment
Influx Healthtech IPO Details
Open Date
18 Jun 2025
Close Date
20 Jun 2025
Lot Size
1200
Min. Investment
₹1,09,200
About Influx Healthtech
Influx Healthtech Limited is a Mumbai-based healthcare company that is in the contract manufacturing space. Established in 2020, it operates as a contract development and manufacturing organisation (CDMO), providing services across various industries. The company’s product offerings include dietary and nutritional supplements, cosmetics, Ayurvedic and herbal formulations, veterinary feed supplements, and homecare products. These are available in multiple forms, including tablets, capsules, powders, liquids, softgels, and creams. Influx Healthtech operates manufacturing facilities in Thane, Maharashtra. The facilities are certified to international quality standards, including Good Manufacturing Practice (GMP), Hazard Analysis and Critical Control Points (HACCP), and Halal.
Founded In
2020
Managing Director
Mr Munir Abdul Ganee Chandniwala
Parent Organization
Influx Healthtech Ltd
Application Details of Influx Healthtech IPO
| Apply as | Price Range | Apply Upto |
|---|---|---|
| Regular | ₹91 - ₹96 | ₹2 Lakh |
| High Networth Individual | ₹91 - ₹96 | ₹2 - 5 Lakh |
Open On12 Dec 2025
Close On16 Dec 2025
Price Range₹2061-2165
Testimonial
Genuine Review Form Statisifed Customers
Starting SIPs with KSquare has brought so much clarity to my finances. Their platform is smooth, and the investment returns speak for themselves.
KSquare’s New Fund Offering updates are timely and insightful. I’ve participated in two NFOs already, and the results have been quite impressive and transparent.
Getting a loan against my mutual funds was hassle-free with KSquare. Very professional and transparent experience.
KSquare gave me clarity in my mutual fund journey. I now know where my money goes and how it grows. Their dashboard is excellent.
KSquare made investing so simple! Their SIP options fit my monthly budget and help me build wealth consistently without worry. I highly recommend it to anyone starting their financial journey.
KSquare helped me invest in Indian markets with zero stress. Their NRI Corner is truly designed for people living abroad.
KSquare not only alerts about NFOs, but they explain fund purpose and performance projections. I truly appreciate that extra layer of detail and care.
I found KSquare’s NFO guides super user-friendly. They cover risks and benefits without overwhelming new investors. Highly recommended for anyone starting out.
I enrolled in NPS through KSquare and found their portal extremely intuitive. Their team guided me at every step.
KSquare’s SIP has brought structure to my investment plan. It's great for disciplined investing, and the automation ensures I never miss a payment. Very happy with the service so far!
FAQ's
Frequenlty Asked Question
Why should I choose KSquare over other platforms for NRI investing?
KSquare offers tailored advice, easy KYC, global access, compliance support, and personal service for NRI investors.
Can NRIs invest in NPS through KSquare?
Yes, NRIs can invest in NPS if they meet KYC norms. KSquare supports NRI onboarding for NPS accounts.
What documentation is needed to invest via KSquare?
You’ll need a valid passport, visa, PAN card, overseas address proof, and NRE/NRO bank details.
What is the minimum amount to start investing with KSquare?
NRIs can begin with as little as ₹1,000 per month depending on the investment vehicle, offering flexible entry points.
Can I switch between mutual funds on KSquare?
Yes, you can easily switch between funds on the KSquare platform based on your strategy or market movements.
Can I track my SIP performance on KSquare?
Yes, KSquare offers detailed tracking tools and insights so you can monitor your SIP performance anytime.
Does KSquare offer mutual funds for tax savings?
Yes, KSquare offers ELSS mutual funds, which are eligible for tax deductions under Section 80C up to ₹1.5 lakh.
Are SIP investments safe?
While SIPs are subject to market risks, long-term investing and diversification help reduce risk and improve returns.